Immunogenicity Assessment of Lipegfilgrastim in Patients with Breast Cancer Receiving Chemotherapy

Lipegfilgrastim is a long-acting, once-per-cycle, glycopegylated recombinant granulocyte colony-stimulating factor (G-CSF) used to prevent neutropenia in patients receiving myelosuppressive chemotherapy. This integrated analysis examined the immunogenicity of lipegfilgrastim and its potential clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Linglong, Buchner, Anton, Roberge, Martin, Liu, Patrick M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935921/
https://www.ncbi.nlm.nih.gov/pubmed/27419145
http://dx.doi.org/10.1155/2016/9248061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935921/
https://www.ncbi.nlm.nih.gov/pubmed/27419145
http://dx.doi.org/10.1155/2016/9248061

Ejemplares similares